Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration
Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration
复制标题
DOI：
10.1016/j.jsat.2020.108267
复制
发表时间：
2021-01-05
影响因子：
3.9
通讯作者：
Chilcoat, Howard
中科院分区：
文献类型：
--
作者：
Monico, Laura B.;Gryczynski, Jan;Chilcoat, Howard
背景：丁丙诺啡治疗仍然无法在许多监狱和监狱，但使用非处方（即。例如，转移）丁丙诺啡已报告在这些设置。本分析的目的是探索背后的经验和动机，最近被监禁的individuals.Methods之间使用转向丁丙诺啡：阿片类药物滥用的成年人谁最近被释放从监狱或监狱（n = 26; 58%男性）完成了半结构化的定性访谈的一部分，一项研究的重点是丁丙诺啡转移在刑事司法系统。定性访谈探讨了参与者的监禁经历和阿片类药物使用背景，监狱/监狱中丁丙诺啡和其他物质使用的知识，监禁期间丁丙诺啡的个人使用，监禁期间使用丁丙诺啡的原因，以及如何将丁丙诺啡带入监狱/监狱并在监狱中获得的知识。该研究记录和转录访谈，并分析了与这些预定的主题领域相关的内容的叙述。结果：从监禁期间围绕丁丙诺啡转移的访谈中出现的关键主题包括：1）在监狱/监狱环境中转移的丁丙诺啡的感知高流行率，2）流行率的感知如何与丁丙诺啡舌下膜剂制剂相关，3）与转移的丁丙诺啡的高成本相关的适应性给药途径，以及4）被监禁的个人使用转移的丁丙诺啡的原因（以达到欣快的效果和科普监禁，而不是像在社区中那样用于自我治疗/戒断管理）。与会者报告说，刑事司法设施中广泛存在被转用的丁丙诺啡，并描述了在这些情况下使用丁丙诺啡的具体原因。需要更多的研究来确定在监狱和监狱中扩大丁丙诺啡治疗对囚犯使用转移的丁丙诺啡的影响，未来的研究应该探索这些交叉点作为治疗开始的机会。
Background: Buprenorphine treatment remains unavailable in many jails and prisons, but use of nonprescribed (i. e., diverted) buprenorphine has been reported in these settings. The purpose of this analysis is to explore the experiences and motivations behind the use of diverted buprenorphine among recently incarcerated individuals.Methods: Adults with opioid misuse who were recently released from jail or prison (n = 26; 58% male) completed semi-structured qualitative interviews as part of a study focused on buprenorphine diversion in the criminal justice system. Qualitative interviews explored participants' incarceration experiences and opioid use background, knowledge of buprenorphine and other substance use in jails/prisons, personal use of buprenorphine while incarcerated, reasons for using buprenorphine while incarcerated, and knowledge of how buprenorphine is brought into and acquired in jails/prisons. The study recorded and transcribed interviews, and analyzed the narratives for content related to these predetermined thematic areas.Results: Key themes emerging from the interviews surrounding buprenorphine diversion during incarceration included: 1) the perceived high prevalence of diverted buprenorphine in jail/prison settings, 2) how the perception of prevalence is related to buprenorphine sublingual film formulation, 3) adaptive routes of administration related to the high cost of diverted buprenorphine, and 4) reasons individuals who are incarcerated use diverted buprenorphine (to achieve euphoric effects and cope with confinement, in contrast to using for self-treatment/withdrawal management as is done in the community).Conclusion: Participants reported widespread availability of diverted buprenorphine in criminal justice facilities, and characterized reasons for its use specific to these contexts. More research is needed to determine the impact of expanding buprenorphine treatment in jails and prisons on inmates' use of diverted buprenorphine, and future research should explore these intersections as treatment initiation opportunities.